SEC Comment Letter 0000000000-24-008507 to KALA BIO, Inc. (KALA) (CIK 0001479419) (KALA)
KALA BIO, Inc. (KALA) (CIK 0001479419)
Date: July 26, 2024 · CIK: 0001479419 · Accession: 0000000000-24-008507
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-281006
Letter
July 26, 2024 Mark Iwicki Chief Executive Officer Kala Bio, Inc. 1167 Massachusetts Avenue Arlington, MA 02476 Re:Kala Bio, Inc. Registration Statement on Form S-3 Filed July 25, 2024 File No. 333-281006 Dear Mark Iwicki: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tamika Sheppard at 202-551-8346 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Andrea Sorrentino
Show Raw Text
July 26, 2024
Mark Iwicki
Chief Executive Officer
Kala Bio, Inc.
1167 Massachusetts Avenue
Arlington, MA 02476
Re:Kala Bio, Inc.
Registration Statement on Form S-3
Filed July 25, 2024
File No. 333-281006
Dear Mark Iwicki:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that
the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tamika Sheppard at 202-551-8346 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Andrea Sorrentino